DADC
CBPO

D.A. Davidson & Co’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

D.A. Davidson & Co’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$11K – 2342
2017
Q2 		$11K Hold
100
– – ﹤0.01% 2025
2017
Q1 		$10K Hold
100
– – ﹤0.01% 2042
2016
Q4 		$10K Buy
+100
New +$11.7K ﹤0.01% 2134

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

D.A. Davidson & Co's CBPO Position: Q3 2017 in Review

D.A. Davidson & Co sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 100 shares — an estimated $11K sold.

D.A. Davidson & Co first reported a position in CBPO in Q4 2016 and held it in 3 quarters. The position peaked at $11K in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • D.A. Davidson & Co reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 100 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $11K.
  • D.A. Davidson & Co first reported a position in China Biologic Products Holdings, Inc. in Q4 2016 and held it in 3 quarters.
  • D.A. Davidson & Co's China Biologic Products Holdings, Inc. position peaked at $11K in Q2 2017.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.